Clinical Trial Update: Phase II Trial of PRT-064040 Nasal Spray for the Treatment of Migraine in Adults [Phase 2]

View source ↗

Summary

Phase II clinical trial update for PRT-064040 nasal spray in adults with migraine; the study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Migraine

Drugs mentioned

• PRT-064040

Snippet

Sponsor: Sichuan Purity Pharmaceutical Technology Co., Ltd. | Conditions: Migraine | Phase 2 | Status: RECRUITING